| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 558.7 | 548.9 |
| Gross profit | 339.8 | 328.9 |
| Profit before tax | -0.5 | -566.9 |
| Net income | 3.1 | -571.1 |
| EPS (diluted, $ a share) | $0.06 | $-9.99 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Revenue, year on year | +1.8% |
|---|---|
| Gross margin | 60.8% |
| Operating margin | 0.6% |
10-Q filed with the SEC, NYSE: ENOV. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Enovis Corp: key numbers
- Share price
- $27.92Close, Nov 16
- Market cap
- $1.61B
- Shares outstanding
- 57.69MLatest SEC cover page
- Sector
- Industrial Applications and Services
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & SuppliesSIC 3842
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Enovis Corp
All →Enovis Director Angela S. Lalor Buys $49.4K of Stock
Angela S. Lalor, Director, bought 1,754 shares of Enovis Corp at $27.71 to $28.29 a share (average $28.16) in 3 transactions, worth $49.4K in total between Nov 12, 2026 and Nov 13, 2026. Shares held after the trade: 34,997 (+2.6%).
- Value
- $49.4K
- Shares
- 1,754
- Average price
- $28.16
- Role
- Director
- Holding change
- +2.6%
- Trade date
- Nov 12, 2026 to Nov 13, 2026
Enovis Director Sharon L. Wienbar Buys $49.8K of Stock
Sharon L. Wienbar, Director, bought 1,774 shares of Enovis Corp at $27.76 to $28.43 a share (average $28.09) in 2 transactions, worth $49.8K in total between Nov 10, 2026 and Nov 11, 2026. Shares held after the trade: 45,551 (+2.0%).
- Value
- $49.8K
- Shares
- 1,774
- Average price
- $28.09
- Role
- Director
- Holding change
- +2.0%
- Trade date
- Nov 10, 2026 to Nov 11, 2026
Enovis Director Angela S. Lalor Buys $50.2K of Stock
Angela S. Lalor, Director, bought 1,757 shares of Enovis Corp at $28.28 to $28.86 a share (average $28.57) in 2 transactions, worth $50.2K in total between Nov 10, 2026 and Nov 11, 2026. Shares held after the trade: 33,243 (+2.7%).
- Value
- $50.2K
- Shares
- 1,757
- Average price
- $28.57
- Role
- Director
- Holding change
- +2.7%
- Trade date
- Nov 10, 2026 to Nov 11, 2026
Enovis Director Sharon L. Wienbar Buys $49.9K of Stock
Sharon L. Wienbar, Director, bought 1,831 shares of Enovis Corp at $26.98 to $27.55 a share (average $27.26) in 2 transactions, worth $49.9K in total between Nov 6, 2026 and Nov 9, 2026. Shares held after the trade: 43,777 (+2.2%).
- Value
- $49.9K
- Shares
- 1,831
- Average price
- $27.26
- Role
- Director
- Holding change
- +2.2%
- Trade date
- Nov 6, 2026 to Nov 9, 2026
Enovis Financial Results
Enovis reported Q3 2026 net sales of $559 million, representing 5% organic growth, driven by a 6% increase in its Reconstructive segment. The company raised its full-year 2026 guidance for adjusted EBITDA and adjusted EPS while announcing a new $200 million share repurchase authorization.
- Term
- Q3 2026
“Our third-quarter results reflect continued progress against our innovation-led strategy and the benefits of executing with greater alignment, accountability, and discipline.”
Damien McDonald, Chief Executive Officer of Enovis
“Growth was consistent with our expectations for the quarter, with continued share gains in Recon and steady performance in Prevention & Recovery.”
Damien McDonald, Chief Executive Officer of Enovis